RxDoctor Payments Data

Kelly Krause, PA

Physician Assistant · Mountain Home, ARNPI 1487063897

Payments from drug & device makers

$1,795in general payments, 2019–2025

Across 99 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$342
  • Amgen$329
  • Lilly USA, LLC$257
  • Sanofi$198
  • AbbVie$152
  • Sun Pharmaceutical Industries Inc.$145
  • plus $371 from 10 others

What the payments were for

  • Food & beverage$1,795100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,795 in reported general payments places this provider in the 75th percentile of 451 physician assistant providers in Arkansas.

See all physician assistant providers in Arkansas

Medicare billing

Part B allowed, 2024
$212,483
Medicare patients
1,205
Services billed
4,154

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab106$424,844
OtezlaApremilast61$338,097
Humira(Cf) PenAdalimumab24$263,821
TremfyaGuselkumab14$189,634
Cosentyx Unoready PenSecukinumab14$125,980
Cosentyx Sensoready (2 Pens)Secukinumab13$87,974
Humira(Cf)Adalimumab11$82,241
Tacrolimus71$9,164
Ketoconazole401$7,352
Fluorouracil108$7,131
Betamethasone Dipropionate93$5,276
Triamcinolone Acetonide354$4,218
Fluocinonide100$3,809
Metronidazole62$3,008
Dapsone13$2,055

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$329$338,09761 claims
Johnson & JohnsonTremfya$342$189,63414 claims
AbbVieHumira(Cf)$152$82,24111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 451 physician assistant providers in Arkansas.

Other physician assistant in Mountain Home

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →